FDA Launches Digital Health Pilot for Chronic Disease Technologies
The pilot will evaluate a new, risk-based enforcement approach that supports digital health devices intended for use in chronic conditions.
The pilot will evaluate a new, risk-based enforcement approach that supports digital health devices intended for use in chronic conditions.
The agency reminds healthcare facilities to follow manufacturer instructions for use and maintenance after reports of fires, serious injuries, and deaths.
The voluntary recall involves pump modules that may have been repaired with FR-110 bezels, which the company says can weaken over time and compromise safe infusion delivery.
The pilot will evaluate a new, risk-based enforcement approach that supports digital health devices intended for use in chronic conditions.
The FDA grants De Novo authorization for a new device for future five-year breast cancer risk prediction, based on an image alone.
Read MoreThe agencies are asking stakeholders to weigh in on a sweeping deregulatory initiative that will eliminate 10 regulations for every one introduced.
Read MoreThe FDA will expand generative AI tools across all centers by June 30 following a successful scientific review pilot, aiming to reduce repetitive tasks and improve operational efficiency.
Read MoreThe FDA is ramping up unannounced inspections at foreign sites producing medical products and other goods to align regulatory oversight with domestic standards.
Read MoreChanges in suppliers and manufacturing locations to avoid tariffs can require new regulatory filings, increasing time and cost burdens across global markets.
Read MoreA former FDA official argues that medical device repair needs stricter oversight to protect patient safety amid growing right to repair efforts.
Read More
The FDA has issued a warning letter to ICU Medical, citing regulatory violations related to unapproved modifications to two of its infusion pumps.